Biotech Values

[ghmm]

RGNX:

I don't think they changed the royalty rate from my notes when I was (very) close to buying I have mid-single to low double digit. The concern was how far out they would pay the royalty given the limited IP on AAV9. I thought in the new deal it clarified a bit about how long the royalty extends but not sure.

No position in RGNX but if the IP extends to the duration of it being on the market if one has any confidence in the asset/license I'd think RGNX should be up A LOT more just on the AVXS royalty not to mention additional premium for their vector/other licensees.